Pure Encapsulations RENUAL vs Timeline Mitopure: Clinician Picks
Pure Encapsulations RENUAL and Timeline Mitopure are two of the most recognizable premium urolithin A products on the shelf. They share more than most shoppers realize, and they differ in ways that matter for how you actually take them. Here is a calm, structure/function comparison of dose, form and how each frames the evidence.
A quick disclosure before we start: SOMA HEALTH makes its own urolithin A product, so we are a competitor to both brands discussed here. We have tried to keep this comparison factual and even-handed, and to point you toward primary research rather than marketing language. Where a product's exact per-serving amount is not something we could verify against a current label as we wrote this, we say so and suggest you check the current label yourself. This article is educational and is not a treatment for any condition; if you are managing a health issue, talk with your own clinician before adding any supplement.
The one fact that reframes this whole comparison
RENUAL and Mitopure are not really competing formulas at the molecular level. Timeline (the brand behind Mitopure) is the consumer arm of Amazentis, the company that developed the branded, highly purified urolithin A used in the published human trials. Pure Encapsulations' RENUAL is a practitioner-channel product that is formulated with that same licensed Mitopure urolithin A. In other words, the active compound inside both is the same branded ingredient. So the meaningful questions are not "whose molecule is better" but rather: what dose does each serving deliver, what format do you have to swallow, and how honestly is the science being described?
What the human evidence actually shows (and what it does not)
Because both products center on the Mitopure form of urolithin A, the strongest human data attach to that ingredient. It is worth being precise about what has and has not been demonstrated in people.
Proven in humans: safety and target engagement
The first-in-human work (Andreux and colleagues, Nature Metabolism, 2019) reported that urolithin A was safe and well tolerated at single doses up to 1,000 mg per day, and that it shifted a mitochondrial gene-expression signature in muscle and blood. That is a meaningful proof-of-concept: the compound is absorbed and appears to reach the biological machinery it targets.
Newer human data: muscle endurance and strength
Two randomized trials build on that foundation. Liu, D'Amico and colleagues (JAMA Network Open, 2022) studied older adults over roughly four months and reported improvements in measures of muscle endurance. Singh and colleagues (Cell Reports Medicine, 2022) studied middle-aged adults for four months using 500 mg and 1,000 mg arms, and reported effects on muscle strength and aspects of exercise performance. More recently, an eight-week randomized trial in resistance-trained men (Journal of the International Society of Sports Nutrition, 2024) and a 2025 trial in distance runners have extended this work into fitter populations, and a 2025 Nature Aging randomized trial over about 28 days reported support for immune-cell mitochondrial health in midlife adults. A 2024 systematic review in Ageing Research Reviews summarized the field fairly: the human evidence is promising but still emerging, with modest sample sizes.
Preclinical only: the more dramatic claims
Much of the excitement around urolithin A traces to laboratory work that has not yet been replicated in humans. Ryu and colleagues (Nature Medicine, 2016) showed that urolithin A induced mitophagy and extended lifespan in the roundworm C. elegans, with muscle benefits in rodents. Later work (D'Amico and colleagues, Aging Cell, 2022) examined joint and cartilage endpoints in osteoarthritis models. These are animal and cell studies. When any brand implies whole-body renewal, longevity or joint repair in people, it is leaning on preclinical signals, and that distinction deserves to be stated plainly.
The mechanism itself is genuinely interesting and worth understanding. Urolithin A is a gut postbiotic: your microbiome makes it from ellagitannins found in pomegranate, walnuts and certain berries. Crucially, only some people carry the gut bacteria needed to convert those precursors efficiently, which is a large part of why a standardized supplement exists at all. Once present, urolithin A supports mitophagy, the housekeeping process that recycles worn-out mitochondria so cells can maintain cleaner energy production. You can read our fuller explainer in the urolithin A guide and a plain-language walkthrough of the trials on our clinical studies page.
RENUAL vs Mitopure: dose and format
Dose
The published trials used 500 mg and 1,000 mg per day of the Mitopure form, with 500 mg being the most commonly studied maintenance amount and 1,000 mg the top dose tested for tolerability. Timeline's Mitopure line and Pure Encapsulations' RENUAL are both built around this branded ingredient, but per-serving amounts and serving sizes can change between formats and over time. Rather than quote figures we cannot stand behind today, we suggest you check the current label on each product and compare milligrams of urolithin A per daily serving directly. Our dosage page explains how to read those numbers and why the daily total matters more than the pill count.
Format
This is where the everyday experience diverges. RENUAL is delivered in Pure Encapsulations' Caplique capsules, a practitioner-style capsule format many people know from that brand. Timeline offers Mitopure in several forms, including softgels, a mixable powder and, more recently, gummies. Neither format changes the underlying compound; they change adherence. A powder suits people who already make a morning shake; capsules suit people who prefer a familiar swallow; chewables suit people who dislike pills or who simply forget capsules. The best format is, unglamorously, the one you will take every day for the several months these trials ran.
How each brand frames the science
Timeline, as the developer of the clinical-grade ingredient, tends to anchor its messaging to the specific published endpoints, particularly muscle strength and endurance. That is the most defensible framing because those are the endpoints the human trials measured. Pure Encapsulations, a professional-channel brand, typically uses conservative structure/function language around muscle function, cellular energy and mitochondrial health. As a general rule, be more skeptical of any listing, from any seller, that promises dramatic longevity, "renewal" of the whole body, or joint outcomes, because those claims outrun the current human data. Honest urolithin A marketing sounds a little boring: it supports mitochondrial quality control and has shown effects on muscle measures over months of daily use.
So which should a clinician pick?
There is no single winner, and anyone who tells you otherwise is selling. A reasonable way to decide: match the format to the person's habits, then compare the milligrams of urolithin A per daily serving against the 500 to 1,000 mg range used in trials, then weigh third-party testing and cost per day. Someone who blends a smoothie may do best with a powder; someone who wants the simplest possible routine at the top studied dose may prefer a four-gummy serving; someone loyal to a practitioner brand may stay with capsules. If you are still mapping the whole category, our roundup of the best urolithin A gummies lays out how we weigh dose, testing and format across brands.
Frequently asked questions
Are RENUAL and Mitopure the same thing?
Not the same product, but they are built on the same branded urolithin A. Timeline is the consumer brand of Amazentis, which developed the Mitopure ingredient, and Pure Encapsulations' RENUAL is formulated with that licensed ingredient. The active compound is the same; format, serving size and brand channel differ.
Which has a higher dose?
Per-serving amounts can change by format and over time, so we do not want to quote figures we cannot verify against a current label. Check the current label on each and compare milligrams of urolithin A per daily serving. The trials used 500 mg and 1,000 mg per day.
Is urolithin A proven to build muscle?
Human randomized trials have reported effects on muscle endurance (older adults) and muscle strength and exercise performance (middle-aged adults) over about four months. The evidence is promising but still emerging, with modest sample sizes. It is not a treatment for any muscle disease.
What about longevity or joint claims?
Those come primarily from preclinical studies in worms, rodents and cell models, not from human trials. They should be described as early research, not established human benefits.
Do I need a supplement if I eat pomegranate and walnuts?
Only some people carry the gut bacteria that efficiently convert dietary ellagitannins into urolithin A, so food intake does not guarantee meaningful levels. A standardized supplement delivers a consistent amount regardless of your microbiome. See our foods and mechanism explainers for detail.
How does SOMA HEALTH compare?
SOMA HEALTH Urolithin A Gummies provide 1,000 mg per daily four-gummy serving, sugar-free, third-party tested, at $79 for a 30-day supply. We are a competitor to RENUAL and Mitopure, so weigh our product against theirs on dose, format, testing and cost per day.
Can I take urolithin A with other supplements or medications?
Urolithin A was well tolerated in trials, but this article is educational and not medical advice. If you take medication or manage a health condition, talk with your own healthcare provider before starting.
Compare SOMA HEALTH Urolithin A Gummies
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.
A clinically studied 1,000 mg dose of Urolithin A in one simple daily gummy — to support mitophagy, muscle strength, and cellular energy.
Shop SOMA Urolithin A Gummies →